AXSM
$179.18-1.59%
as of close, Oct 2, 2026
☾ AH $179.18 -1.59%
Axsome Therapeutics Inc.Stock · Health CareNasdaq Composite 0.03%Russell 1000 0.02%US Stock Market 0.01%Russell 3000 0.01%
AXSM financial statements
The full income statement, balance sheet, and cash-flow statement for Axsome Therapeutics Inc. (AXSM), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 48.0M2024-09 48.5M2024-12 48.8M2025-03 49.2M2025-06 49.9M2025-09 50.4M2025-12 51.2M2026-03 51.5M2026-06 52.4M+9.1% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 638M+65.5% | 386M+42.5% | 271M+440.8% | 50.0M | — | |
| Cost of revenue | — | — | — | 5.20M | — | |
| — | — | — | — | 125M+25.8% | ||
| Research & development | 183M-2.0% | 187M+91.0% | 97.9M+69.0% | 57.9M-0.2% | 58.1M-17.3% | |
| Selling, general & administrative | 571M+38.7% | 411M+27.3% | 323M+102.9% | 159M+139.0% | 66.6M+130.6% | |
| General & administrative | 63.3M+16.7% | 54.2M+45.1% | 37.4M+46.6% | 25.5M-61.8% | 66.6M+130.6% | |
| Selling & marketing | 440M+50.1% | 293M+23.7% | 237M+126.7% | 105M | — | |
| Amortization of intangibles | 6.38M-0.3% | 6.39M+0.3% | 6.38M+54.0% | 4.14M | — | |
| Operating income | -167M+40.6% | -281M-21.0% | -232M-28.9% | -180M-44.2% | -125M-25.8% | |
| Interest expense | -15.9M+26.2% | -21.6M-7.7% | -20.0M-107.4% | -9.66M | — | |
| Interest & investment income | 9.37M-37.6% | 15.0M+10.5% | 13.6M+484.4% | 2.32M | — | |
| Pre-tax income | -184M+36.0% | -287M-20.5% | -238M-27.3% | -187M-43.5% | -130M | |
| Income tax | -530K-723.5% | 85.0K-91.1% | 960K | 0.00 | 0.00 | |
| Net income | -183M+36.2% | -287M-20.1% | -239M-27.8% | -187M-43.5% | -130M-26.7% | |
| -$3.68+38.6% | -$5.99-13.7% | -$5.27-14.6% | -$4.60-32.6% | -$3.47-25.3% | ||
| EPS (basic) | -$3.68+38.6% | -$5.99-13.7% | -$5.27-14.6% | -$4.60-32.6% | -$3.47-25.3% | |
| Weighted-avg shares (basic) | 49.7M+3.8% | 47.9M+5.5% | 45.4M+11.7% | 40.7M+8.1% | 37.6M+1.1% | |
| Weighted-avg shares (diluted) | 49.7M+3.8% | 47.9M+5.5% | 45.4M+11.7% | 40.7M+8.1% | 37.6M+1.1% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 589M+21.4% | 485M-3.8% | 504M+105.3% | 246M+183.9% | 86.5M-53.0% | ||
| Cash & equivalents | 323M+2.4% | 315M-18.3% | 386M+92.3% | 201M+132.3% | 86.5M-53.0% | |
| Accounts receivable | 224M+58.1% | 142M+49.8% | 94.8M+151.5% | 37.7M | — | |
| Inventory | 27.9M+77.6% | 15.7M+3.9% | 15.1M+250.3% | 4.32M | — | |
| Prepaid expenses | 13.7M+14.0% | 12.0M+47.6% | 8.12M+191.8% | 2.78M+6041.0% | 45.3K-69.5% | |
| 690M+21.3% | 568M-3.4% | 588M+77.5% | 331M+277.6% | 87.8M-52.8% | ||
| Property, plant & equipment | 562K-3.8% | 584K-31.0% | 846K+17.2% | 722K+154.4% | 284K+439.1% | |
| Operating lease right-of-use | 20.9M+287.5% | 5.38M-20.5% | 6.77M+1512.4% | 420K-36.4% | 660K-62.0% | |
| Goodwill | 12.0M+0.0% | 12.0M+0.0% | 12.0M+16.8% | 10.3M | — | |
| Intangible assets | 40.5M-13.6% | 46.9M-12.0% | 53.3M-10.7% | 59.7M | — | |
| Other non-current assets | — | — | — | — | 323K+1.7% | |
| 379M+64.6% | 230M+65.7% | 139M+43.8% | 96.6M+318.6% | 23.1M-1.6% | ||
| Accounts payable | 65.5M-9.0% | 72.0M+77.0% | 40.7M+5.4% | 38.6M+193.6% | 13.1M-2.6% | |
| Short-term & current debt | 70.0M | 0.00 | — | — | — | |
| Current lease liability | 434K-76.3% | 1.83M+44.8% | 1.27M+198.1% | 425K-31.5% | 621K-49.1% | |
| Finance lease liability (current) | 2.54M+79.1% | 1.42M | — | — | — | |
| 602M+17.6% | 511M+28.8% | 397M+79.0% | 222M+207.6% | 72.2M-0.3% | ||
| Long-term debt | 118M-34.8% | 181M+1.5% | 178M+88.9% | 94.3M+92.0% | 49.1M+1.6% | |
| Non-current lease liability | 23.2M+283.4% | 6.05M-14.1% | 7.04M | — | — | |
| Operating lease liability (total) | 23.6M+199.7% | 7.88M-5.1% | 8.30M+1854.9% | 425K-31.6% | 621K-65.6% | |
| Finance lease liability (total) | 6.80M+55.8% | 4.37M | — | — | — | |
| Finance lease liability | 4.21M+42.9% | 2.94M | — | — | — | |
| 88.3M+54.9% | 57.0M-70.1% | 191M+74.3% | 110M+600.9% | 15.6M-86.3% | ||
| Common stock | 5.00K+0.0% | 5.00K+0.0% | 5.00K+25.0% | 4.00K+5.8% | 3.78K+1.2% | |
| Additional paid-in capital | 1.39B+18.2% | 1.18B+14.9% | 1.03B+45.4% | 706M+66.2% | 425M+8.2% | |
| Retained earnings | -1.31B-16.3% | -1.12B-34.4% | -836M-40.1% | -596M-45.7% | -409M-46.8% | |
| Total liabilities & equity | 690M+21.3% | 568M-3.4% | 588M+77.5% | 331M+277.6% | 87.8M-52.8% | |
| Common shares issued | 50.9M+4.6% | 48.7M+2.8% | 47.4M+8.9% | 43.5M+15.0% | 37.8M+1.2% | |
| Common shares outstanding | 50.9M+4.6% | 48.7M+2.8% | 47.4M+8.9% | 43.5M+15.0% | 37.8M+1.2% | |
| Shares outstanding (cover) | 51.2M+4.9% | 48.8M+2.9% | 47.4M+8.9% | 43.5M+13.1% | 38.5M+2.9% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| -93.4M+27.3% | -128M+11.5% | -145M-24.5% | -117M-7.7% | -108M-37.9% | ||
| Depreciation & amortization | 6.88M-0.7% | 6.92M+1.3% | 6.83M+55.2% | 4.40M+5692.1% | 76.0K+218.5% | |
| Intangible amortization | 6.38M-0.3% | 6.39M+0.3% | 6.38M+54.0% | 4.14M | — | |
| Share-based compensation | 93.8M+10.0% | 85.2M+36.1% | 62.6M+66.0% | 37.7M+81.3% | 20.8M+41.0% | |
| Change in receivables | 82.5M+74.8% | 47.2M-17.4% | 57.1M+51.5% | 37.7M | — | |
| Change in inventory | 10.7M+1532.8% | -744K-109.1% | 8.16M+512.8% | 1.33M | — | |
| Change in payables | -6.46M-120.6% | 31.3M+1410.0% | 2.07M-91.9% | 25.5M+7270.7% | -355K-113.9% | |
| -480K-77.8% | -270K+53.6% | -582K+98.9% | -53.7M-17335.7% | -308K-571.2% | ||
| Capital expenditure | 480K+77.8% | 270K-53.6% | 582K-17.1% | 702K+127.9% | 308K+571.2% | |
| Free cash flow | -93.9M+27.0% | -129M+11.7% | -146M-24.3% | -117M-8.0% | -109M-38.3% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 101M+75.4% | 57.8M-82.5% | 331M+16.3% | 285M+2456.9% | 11.1M-73.8% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | |
| Long-term debt repaid | 332M | 0.00 | 0.00 | 0.00 | 0.00-100.0% | |
| Common stock issued | 67.9M+66.5% | 40.8M-84.2% | 259M+6.1% | 244M+3178.1% | 7.44M-47.4% | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net change in cash | 7.58M+110.7% | -70.8M-138.2% | 185M+62.1% | 114M+217.4% | -97.4M-169.9% | |
| Interest paid | 14.6M-25.7% | 19.7M+17.7% | 16.7M+117.7% | 7.69M+66.2% | 4.63M+120.5% | |
| Income taxes paid | -180K | — | — | — | — | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 9.34B+126.4% | 4.13B+9.6% | 3.77B+12.4% | 3.35B+130.4% | 1.45B-52.3% | |
| P/S | 14.6×+36.8% | 10.7×-36.5% | 16.9× | — | — | |
| P/B | 105.8×+46.2% | 72.4×+417.9% | 14.0×-34.3% | 21.3×-77.1% | 93.0×+247.3% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: AXSM’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all AXSM filings on SEC EDGAR → Not investment advice.